The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Open accessAbstract
Captopril, an inhibitor of angiotensin converting enzyme, is widely used clinically to manage hypertension and congestive heart failure. Here captopril is shown to be an inhibitor of angiogenesis able to block neovascularization induced in the rat cornea. Captopril acted directly and specifically on capillary endothelial cells, inhibiting their chemotaxis with a biphasic dose-response curve showing an initial decrease at clinically achievable doses under 10 microM and a further slow decline in the millimolar range. Captopril inhibition of endothelial cell migration was not mediated by angiotensin converting enzyme inhibition, but was suppressed by zinc. Direct inhibition by captopril of zinc-dependent endothelial cell-derived 72-and 92-kD metalloproteinases known to be essential for angiogenesis was also seen. When used systemically on rats captopril inhibited corneal neovascularization and showed the antitumor activity expected of an inhibitor of angiogenesis, decreasing the number of mitoses present in carcinogen-induced foci of preneoplastic liver cells and slowing the growth rate of an experimental fibrosarcoma whose cells were resistant to captopril in vitro. These data define this widely used drug as a new inhibitor of neovascularization and raise the possibility that patients on long term captopril therapy may derive unexpected benefits from its antiangiogenic activities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Folkman, J., & Klagsbrun, M. (1987) · Science · doi:10.1126/science.2432664 · Cited by 3,491
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
New principle for the analysis of chemical carcinogenesis
SOLT, D., & FARBER, E. (1976) · Nature · doi:10.1038/263701a0 · Cited by 786
Self-citationTolsma, S., Volpert, O., Good, D., Frazier, W., Polverini, P., & Bouck, N. (1993) · The Journal of cell biology · doi:10.1083/jcb.122.2.497 · Cited by 573
Self-citationHerron, G. S., Banda, M. J., Clark, E. J., Gavrilovic, J., & Werb, Z. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35860-x · Cited by 525
(1996) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60862-3 · Cited by 510
Emoto, N., & Yanagisawa, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.25.15262 · Cited by 499
Identification of an Inhibitor of Neovascularization from Cartilage
Moses, M. A., Sudhalter, J., & Langer, R. (1990) · Science · doi:10.1126/science.1694043 · Cited by 477
Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit.
Chobanian, A. V., Haudenschild, C. C., Nickerson, C., & Drago, R. (1990) · Hypertension · doi:10.1161/01.hyp.15.3.327 · Cited by 411
Neovascularization produced by angiotensin II.
Fernandez, L. A., Twickler, J., & Mead, A. (1985) · PubMed · Cited by 406
Polverini, P. J., & Leibovich, S. J. (1984) · PubMed · Cited by 360
Self-citationMurphy, A. N., Unsworth, E. J., & Stetler‐Stevenson, W. G. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570219 · Cited by 351
Tannock, I. F. (1970) · PubMed · Cited by 242
Partial purification and characterization of a neutral protease which cleaves type IV collagen
Liotta, L. A., Tryggvason, K., Garbisa, S., Robey, P. G., & Abe, S. (1981) · Biochemistry · doi:10.1021/bi00504a017 · Cited by 240
Interstitial Collagenase Is Required for Angiogenesis in Vitro
Fisher, C., Gilbertson-Beadling, S., Powers, E. A., Petzold, G., Poorman, R., & Mitchell, M. A. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1104 · Cited by 227
Tsuboi, R., Sato, Y., & Rifkin, D. B. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.2.511 · Cited by 202
Influence of the angiotensin system on endothelial and smooth muscle cell migration.
Bell, L. B., & Madri, J. A. (1990) · Europe PMC (PubMed Central) · Cited by 181
Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo
Le Noble, F. A. C., Hekking, J. W. M., Van Straaten, H. W. M., Slaaf, D. W., & Struyker Boudier, H. A. J. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90552-2 · Cited by 179
Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats.
Wang, D. H., & Prewitt, R. L. (1990) · Hypertension · doi:10.1161/01.hyp.15.1.68 · Cited by 164
CAPTOPRIL: A NEW TREATMENT FOR RHEUMATOID ARTHRITIS?
Martin, M. F. R., Mckenna, F., Bird, H. A., Surrall, K. E., Dixon, J. S., & Wright, V. (1984) · The Lancet · doi:10.1016/s0140-6736(84)91821-x · Cited by 159
Purification and characterization of endothelin-converting enzyme from rat lung.
Takahashi, M., Matsushita, Y., Iijima, Y., & Tanzawa, K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36936-4 · Cited by 153
Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular Diseases
Duchin, K. L., McKinstry, D. N., Cohen, A. I., & Migdalof, B. H. (1988) · Clinical Pharmacokinetics · doi:10.2165/00003088-198814040-00002 · Cited by 151
Takigawa, M., Nishida, Y., Suzuki, F., et al. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90822-5 · Cited by 151
le Noble, F. A. C., Schreurs, N. H., van Straaten, H. W. M., Slaaf, D. W., Smits, J. F. M., Rogg, H., & Struijker-Boudier, H. A. J. (1993) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1993.264.2.r460 · Cited by 127
Matsubara, T., Saura, R., Hirohata, K., & Ziff, M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113853 · Cited by 123
Captopril: Pharmacology, Metabolism, and Disposition
Migdalof, B. H., Antonaccio, M. J., Kinstry, D. N. M., Singhvi, S. M., Lan, S.-J., Egli, P., & Kripalani, K. J. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409041080 · Cited by 103
Ward, W. F., Kim, Y. T., Molteni, A., & Solliday, N. H. (1988) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(88)90357-4 · Cited by 95
Self-citationIsolation and characterization of an inhibitor of neovascularization from scapular chondrocytes.
Moses, M. A., Sudhalter, J., & Langer, R. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.119.2.475 · Cited by 94
Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril.
Örning, L., Krivi, G. G., Bild, G. S., Gierse, J. K., Aykent, S., & Fitzpatrick, F. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55329-1 · Cited by 90
Thrombospondin stimulates motility of human neutrophils.
Mansfield, P. J., Boxer, L. A., & Suchard, S. J. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.111.6.3077 · Cited by 86
Ahn, K., Pan, S. M., Beningo, K. A., et al. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00227-w · Cited by 85
Kreft-Jaïs, C., Plouin, P., Tchobroutsky, C., & Boutroy, M. (1988) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1988.tb06619.x · Cited by 76
Salt intake and angiotensin II alter microvessel density in the cremaster muscle of normal rats
Hernández, I., Cowley, A. W., Lombard, J. H., & Greene, A. S. (1992) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1992.263.3.h664 · Cited by 76
Angiotensin-Converting Enzyme Inhibitors in Hypertension
Materson, B. J. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.5.513 · Cited by 74
Assay and purification of naturally occurring inhibitor of angiogenesis
Polverini, P. J., Bouck, N., & Rastinejad, F. (1991) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(91)98044-7 · Cited by 70
Self-citationThe effect of Captopril on benign and malignant reactions in irradiated rat skin
Ward, W. F., Molteni, A., Ts'ao, C., & Hinz, J. M. (1990) · British Journal of Radiology · doi:10.1259/0007-1285-63-749-349 · Cited by 58
Self-citationWarren, J. B., & Loi, R. K. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.5.7896012 · Cited by 55
The Expanding Role of Angiotensin Converting Enzyme Inhibitors in the Management of Hypertension
Burris, J. F. (1995) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1995.tb04070.x · Cited by 32
[11] Assay of capillary endothelial cell migration
Zetter, B. R. (1987) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(87)47104-8 · Cited by 24
Young, J. B. (1994) · International Journal of Cardiology · doi:10.1016/0167-5273(94)90004-3 · Cited by 20
Role of sulfhydryl groups an the stimulatory effect of captopril on vascular prostacyclin synthesis
Guivernau, M., Armijo, F., & Rosas, R. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90554-4 · Cited by 10
Captopril and Diabetic Nephropathy
Lewis, E. J. (1995) · JAMA · doi:10.1001/jama.1995.03520470039015 · Cited by 7
Cited by
Vandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Microcirculation in Hypertension: A New Target for Treatment?
Levy, B. I., Ambrosio, G., Pries, A. R., & Struijker-Boudier, H. A. J. (2001) · Circulation · doi:10.1161/hc3101.091158 · Cited by 637
Tumor targeting with a selective gelatinase inhibitor
Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., et al. (1999) · Nature Biotechnology · doi:10.1038/11703 · Cited by 567
Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer?
Lever, A. F., Hole, D. J., Gillis, C. R., McCallum, I. R., McInnes, G. T., MacKinnon, P. L., Meredith, P. A., Murray, L. S., Reid, J. L., & Robertson, J. W. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03228-0 · Cited by 545
The renin–angiotensin system and cancer: old dog, new tricks
George, A. J., Thomas, W. G., & Hannan, R. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2945 · Cited by 525
Metadata
- Authors
- Volpert, O. V., Ward, W. F., Lingen, M. W., Chesler, L., Solt, D. B., Johnson, M. D., Molteni, A., Polverini, P. J., & Bouck, N. P.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-08-01
- Volume
- 98
- Issue
- 3
- Pages
- 671-679
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2017640925
- Cited by
- 323
- References
- 47
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.